Precision neuroimmunology in multiple sclerosis - the horizon is near

Jiwon Oh¹, Amit Bar-Or^{2

3}

Affiliations

¹ Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
² Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. amitbar@pennmedicine.upenn.edu.
³ Multiple Sclerosis Division, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. amitbar@pennmedicine.upenn.edu.

Comment

Jiwon Oh et al. Nat Rev Neurol. 2024 Sep.

. 2024 Sep;20(9):507-508.

doi: 10.1038/s41582-024-00992-6.

Jiwon Oh¹, Amit Bar-Or^{2

3}

¹ Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
² Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. amitbar@pennmedicine.upenn.edu.
³ Multiple Sclerosis Division, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. amitbar@pennmedicine.upenn.edu.

No abstract available

Comment on

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Gross CC, Schulte-Mecklenbeck A, Steinberg OV, Wirth T, Lauks S, Bittner S, Schindler P, Baranzini SE, Groppa S, Bellmann-Strobl J, Bünger N, Chien C, Dawin E, Eveslage M, Fleischer V, Gonzalez-Escamilla G, Gisevius B, Haas J, Kerschensteiner M, Kirstein L, Korsukewitz C, Lohmann L, Lünemann JD, Luessi F, Meyer Zu Hörste G, Motte J, Ruck T, Ruprecht K, Schwab N, Steffen F, Meuth SG, Paul F, Wildemann B, Kümpfel T, Gold R, Hahn T, Zipp F, Klotz L, Wiendl H; German Competence Network Multiple Sclerosis (KKNMS). Gross CC, et al. Sci Transl Med. 2024 Mar 27;16(740):eade8560. doi: 10.1126/scitranslmed.ade8560. Epub 2024 Mar 27. Sci Transl Med. 2024. PMID: 38536936

1. Zamecnik, C. R. et al. An autoantibody signature predictive for multiple sclerosis. Nat. Med. 30, 1300–1308 (2024). - DOI - PubMed
1. Gross, C. C. et al. Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories. Sci. Transl. Med. 16, eade8560 (2024). - DOI - PubMed
1. Kavaliunas, A. et al. Importance of early treatment initiation in the clinical course of multiple sclerosis. Mult. Scler. 23, 1233–1240 (2017). - DOI - PubMed
1. University of California San Francisco MS-EPIC Team et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann. Neurol. 80, 499–510 (2016). - DOI - PMC
1. De Stefano, N. et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 74, 1868–1876 (2010). - DOI - PubMed